INDOCIN
- Product NDC
- 42211-101
- 11-digit product format
- 422110101
- Labeler code
- 42211
- Product ID
- 42211-101_cbb49cf2-5c9b-4c5c-8d5b-7efbfdde1355
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- indomethacin
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Iroko Pharmaceuticals, LLC
- Application
- NDA018332
- Marketing category
- NDA
- Marketing start
- 1985-10-10
- Marketing end
- 0000-00-00
- Substance
- INDOMETHACIN
- Active strength
- 25 mg/5mL
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 42211-101 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 42211-101 | 42211-101-01 | I | Inactivated by FDA | 2026-08-03 | |
| excluded package | package | 42211-101 | 42211-101-11 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42211-101-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42211-101-11 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42211-101-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42211-101-11 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42211-101-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42211-101-11 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42211-101-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42211-101-11 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42211-101-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42211-101-11 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42211-101-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42211-101-11 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42211-101-01 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42211-101-11 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42211-101-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42211-101-11 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42211-101-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42211-101-11 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42211-101-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42211-101-11 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42211-101-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42211-101-11 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42211-101-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42211-101-11 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 42211-101-01 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 42211-101-11 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 42211-101-01 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 42211-101-11 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 42211-101-01 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 42211-101-11 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 42211-101-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 42211-101-11 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 42211-101-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 42211-101-11 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 42211-101-01 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 42211-101-11 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 42211-101-01 | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 42211-101-11 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 42211-101-01 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 42211-101-11 | e2bbac7714bc… | 27bdfed8d636… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018332-001 | INDOCIN | INDOMETHACIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N018332-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | AB | RLD, RS | 1985-10-10 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N018332-001 | INDOCIN | 25MG/5ML | SUSPENSION / ORAL | RLD, RS | 1985-10-10 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N018332-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018332-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N018332-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018332-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018332-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018332-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018332-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018332-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018332-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N018332-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018332-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018332-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018332-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N018332-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018332-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N018332-001 | AB | 1 | 1c564ffb4f44… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N018332-001 | AB | 1 | a50c72e98297… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 234b5275-84d6-d169-e08f-554a8aed3f0a | Product name | 3 | 20250717 |
| 9aaf7cf4-60c3-b44f-e302-fd8b276c713b | Product name | 2 | 20250107 |
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| c6b2f0e9-1a13-02e4-f789-55c724469f07 | Product name | 7 | 20171115 |
| 6e9718b9-62b9-458f-9408-30d688800922 | Product name | 1 | 20171103 |
| d62774ab-b1b9-2d5c-924f-1948e411ae15 | Product name | 3 | 20170816 |
| 97c70338-ee37-4c78-a047-53ee1cd9b53d | Product name | 1 | 20150616 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42211-101-01 | INDOCIN | 1 in 1 CARTON | SUSPENSION | 1 | 11 | |
| 42211-101-01 | INDOCIN | 50 mL in 1 BOTTLE | SUSPENSION | 50 | 11 | |
| 42211-101-11 | INDOCIN | 237 mL in 1 BOTTLE | SUSPENSION | 237 | 11 | |
| 42211-101-11 | INDOCIN | 1 in 1 CARTON | SUSPENSION | 1 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42211-101-11 | ML - Milliliter | 42211-101 | 99d472b3-b858-4ecd-bae6-2dd78de9023d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| INDOMETHACIN | ACTIVE INGREDIENT | XXE1CET956 | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| INDOMETHACIN | ACTIVE MOIETY | XXE1CET956 | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| TRAGACANTH | INACTIVE INGREDIENT | 2944357O2O | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | INDOCIN (INDOMETHACIN) SUSPENSION [IROKO PHARMACEUTICALS, LLC] | 9 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Indocin | INDOMETHACIN | Zyla Life Sciences US LLC | 73878376-1d24-423b-9f37-3666e83c95da | 2024-12-16 | Boxed warning, Warnings, Adverse reactions | 018332 NDA018332 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 206971 | Indocin 25 MG in 5 mL Oral Suspension | PSN | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 310991 | indomethacin 25 MG in 5 mL Oral Suspension | PSN | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 206971 | indomethacin 5 MG/ML Oral Suspension [Indocin] | SBD | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 310991 | indomethacin 5 MG/ML Oral Suspension | SCD | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 206971 | Indocin 25 MG per 5 ML Oral Suspension | SY | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 206971 | Indocin 5 MG/ML Oral Suspension | SY | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
| 310991 | indomethacin 25 MG per 5 ML Oral Suspension | SY | 06de3c9d-63bf-47c1-f78c-4fbdd482928a | 11 |
Packages#
| Package NDC | 11-digit format | Description | Units | Status |
|---|---|---|---|---|
| 42211-101-01 | 42211010101 | 1 in 1 CARTON | Historical | |
| 42211-101-11 | 42211010111 | 237 mL in 1 BOTTLE | 237 ml | Historical |